Your browser doesn't support javascript.
loading
Childhood attention-deficit hyperactivity disorder: socioeconomic inequalities in symptoms, impact, diagnosis and medication.
Pearce, Anna; Henery, Paul; Katikireddi, S Vittal; Dundas, Ruth; Leyland, Alastair H; Nicholls, Dasha; Viner, Russell M; Fenton, Lynda; Hope, Steven.
Afiliação
  • Pearce A; University of Glasgow, Glasgow, UK.
  • Henery P; Public Health Scotland, Edinburgh and Glasgow, UK.
  • Katikireddi SV; University of Glasgow, Glasgow, UK.
  • Dundas R; University of Glasgow, Glasgow, UK.
  • Leyland AH; University of Glasgow, Glasgow, UK.
  • Nicholls D; Imperial College London, London, UK.
  • Viner RM; University College London, London, UK.
  • Fenton L; Public Health Scotland, Edinburgh and Glasgow, UK.
  • Hope S; University College London, London, UK.
Child Adolesc Ment Health ; 29(2): 126-135, 2024 May.
Article em En | MEDLINE | ID: mdl-38497431
ABSTRACT

BACKGROUND:

Children from disadvantaged backgrounds are at greater risk of attention-deficit hyperactivity disorder (ADHD)-related symptoms, being diagnosed with ADHD, and being prescribed ADHD medications. We aimed to examine how inequalities manifest across the 'patient journey', from perceptions of impacts of ADHD symptoms on daily life, to the propensity to seek and receive a diagnosis and treatment.

METHODS:

We investigated four 'stages' (1) symptoms, (2) caregiver perception of impact, (3) diagnosis and (4) medication, in two data sets UK Millennium Cohort Study (MCS, analytic n ~ 9,000), with relevant (parent-reported) information on all four stages (until 14 years); and a population-wide 'administrative cohort', which includes symptoms (child health checks) and prescriptions (dispensing records), born in Scotland, 2010-2012 (analytic n ~ 100,000), until ~6 years. We described inequalities according to maternal occupational status, with percentages and relative indices of inequality (RII).

RESULTS:

The prevalence of ADHD symptoms and medication receipt was considerably higher in the least compared to the most advantaged children in the administrative cohort (RIIs of 5.9 [5.5-6.4] and 8.1 [4.2-15.6]) and the MCS (3.08 [2.68-3.55], 3.75 [2.21-6.36]). MCS analyses highlighted complexities between these two stages, however, those from least advantaged backgrounds, with ADHD symptoms, were the least likely to perceive impacts on daily life (15.7% vs. average 19.5%) and to progress from diagnosis to medication (44.1% vs. average 72.5%).

CONCLUSIONS:

Despite large inequalities in ADHD symptoms and medication, parents from the least advantaged backgrounds were less likely to report impacts of ADHD symptoms on daily life, and their children were less likely to have received medication postdiagnosis, highlighting how patient journeys differed according to socioeconomic circumstances.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno do Deficit de Atenção com Hiperatividade Limite: Child / Female / Humans Idioma: En Revista: Child Adolesc Ment Health Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno do Deficit de Atenção com Hiperatividade Limite: Child / Female / Humans Idioma: En Revista: Child Adolesc Ment Health Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido